Heterogeneity in norovirus shedding duration affects community risk

Epidemiology and Infection

Volumn 141, Issue 8, 2013, Pages 1572-1584

  Milbrath, M O ^a   Spicknall, I H ^a   Zelner, J L ^a   Moe, C L ^b   Eisenberg, J N S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Epidemiology; Norwalk agent and related viruses; risk assessment; Susceptible Infected Removed (SIR) model; transmission

Indexed keywords

CALCULATION; DISEASE SEVERITY; EPIDEMIC; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; NONHUMAN; NOROVIRUS; POPULATION RESEARCH; PREDICTION; PROBABILITY; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SIMULATION; STOCHASTIC MODEL; VIRUS SHEDDING; VIRUS TRANSMISSION;

CALICIVIRIDAE INFECTIONS; DISEASE OUTBREAKS; GASTROENTERITIS; HUMANS; MODELS, BIOLOGICAL; NOROVIRUS; RISK FACTORS; VIRUS SHEDDING;

EID: 84880352928     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813000496     Document Type: Review

References (52)

1. Fankhauser RL, et al. Epidemiologic and molecular trends of 'Norwalk-like viruses' associated with outbreaks of gastroenteritis in the United States. Journal of Infectious Diseases 2002; 186: 1-7.
2. Patel MM, et al. Noroviruses: A comprehensive review. Journal of Clinical Virology 2009; 44: 1-8.
3. Lopman BA, et al. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clinical Infectious Diseases 2011; 52: 466-474.
4. Lopman B, et al. Environmental transmission of norovirus gastroenteritis. Current Opinion in Virology 2012; 2: 96-102.
5. Tam CC, et al. Changes in causes of acute gastroenteritis in the United Kingdom over 15 years: Microbiologic findings from 2 prospective, population-based studies of infectious intestinal disease. Clinical Infectious Diseases 2012; 54: 1275-1286.
6. Sukhrie FHA, et al. Chronic shedders as reservoir for nosocomial transmission of norovirus. Journal of Clinical Microbiology 2010; 48: 4303-4305.
7. Ozawa K, et al. Norovirus infections in symptomatic and asymptomatic food handlers in Japan. Journal of Clinical Microbiology 2007; 45: 3996-4005.
8. Atmar RL, et al. Norwalk virus shedding after experimental human infection. Emerging Infectious Diseases 2008; 14: 1553-1557.
9. Tu ETV, et al. Norovirus excretion in an aged-care setting. Journal of Clinical Microbiology 2008; 46: 2119-2121.
10. Aoki Y, et al. Duration of norovirus excretion and the longitudinal course of viral load in norovirus-infected elderly patients. The Journal of hospital infection 2010; 75: 42-6.
11. Gallimore CI, et al. Asymptomatic and symptomatic excretion of Noroviruses during a hospital outbreak of gastroenteritis. Journal of Clinical Microbiology 2004; 42: 2271-2274.
12. Rockx B, et al. Natural history of human Calicivirus infection: A prospective cohort study. Clinical Infectious Diseases 2002; 35: 246-253.
13. Vanderpas J, et al. Mathematical model for the control of nosocomial norovirus. Journal of Hospital Infection 2009; 71: 214-222.
14. Murata T, et al. Prolonged norovirus shedding in infants 46 months of age with gastroenteritis. Pediatric Infectious Disease Journal 2007; 26: 46-49.
15. Henke-Gendo C, et al. New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children. Journal of Clinical Microbiology 2009; 47: 2855-2862.
16. Furuya D, et al. Age, viral copy number, and immunosuppressive therapy affect the duration of norovirus RNA excretion in inpatients diagnosed with norovirus infection. apanese Journal of Infectious Diseases 2011; 64: 104-108.
17. Lee BY, et al. Economic impact of outbreaks of norovirus infection in hospitals. Infection Control and Hospital Epidemiology 2011; 32: 191-193.
18. Zelner JL, et al. How infections propagate after point-source outbreaks: An analysis of secondary norovirus transmission. Epidemiology 2010; 21: 711-718.
19. Amar CFL, et al. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: Re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996). European Journal of Clinical Microbiology and Infectious Diseases 2007; 26: 311-323.
20. Li D, et al. Critical studies on binding-based RT-PCR detection of infectious Noroviruses. Journal of Virological Methods 2011; 177: 153-9.
21. Teunis PFM, et al. Norwalk virus: How infectious is it? Journal of Medical Virology 2008; 80: 1468-1476.
22. Yezli S, Otter JA. Minimum infective dose of the major human respiratory and enteric viruses transmitted through food and the environment. Food and Environmental Virology 2011; 3: 1-30.
23. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. New England Journal of Medicine 2009; 361: 1776-1785.
24. Leon JS, et al. Randomized, double-blinded clinical trial for human norovirus inactivation in oysters by high hydrostatic pressure processing. Applied and Environmental Microbiology 2011; 77: 5476-5482.
25. Goller JL, et al. Long-term features of norovirus gastroenteritis in the elderly. Journal of Hospital Infection 2004; 58: 286-291.
26. Seitz SR, et al. Norovirus human infectivity and persistence in water. Applied and Environmental Microbiology 2011; 77: 6884-6888.
27. Höhne M, Schreier E. Detection and characterization of norovirus outbreaks in Germany: Application of a one-tube RT-PCR using a fluorogenic real-time detection system. Journal of Medical Virology 2004; 72: 312-319.
28. Sartwell PE. The incubation period and the dynamics of infectious disease. American Journal of Epidemiology 1966; 83: 204-216.
29. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2010.
30. Marshall JA, et al. High level excretion of Norwalk-like virus following resolution of clinical illness. Pathology 2001; 33: 50-52.
31. Hamilton B, Martin J, Ventura S. Preliminary data for 2007. National Vital Statistics Reports 2009; 57.
32. US Census Bureau. State and county quick facts, 2009 (http://quickfacts. census.gov/qfd/states/00000.html). Accessed: 26 October 2010.
33. Kemper AR, Davis MM, Freed GL. Expected adverse events in a mass smallpox vaccination campaign. Effective Clinical Practice 2002; 5: 84-90.
34. Anderson RM, May RM. Infectious Diseases of Humans Dynamics and Control. Oxford: Oxford University Press, 1992.
35. Gallimore CI, et al. Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH). Journal of Clinical Virology 2004; 30: 196-204.
36. Florescu DF, et al. Two cases of Norwalk virus enteritis following small bowel transplantation treated with oral human serum immunoglobulin. Pediatric Transplantation 2008; 12: 372-375.
37. Lee BE, et al. Chronic norovirus and adenovirus infection in a solid organ transplant recipient. Pediatric Infectious Disease Journal 2008; 27: 360-362.
38. Nilsson M, et al. Evolution of human calicivirus RNA in vivo: Accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. Journal of Virology 2003; 77: 13117-13 124.
39. Schorn R, et al. Chronic norovirus infection after kidney transplantation: Molecular evidence for immune-driven viral evolution. Clinical Infectious Diseases 2010; 51: 307-314.
40. Westhoff TH, et al. Chronic norovirus infection in renal transplant recipients. Nephrology Dialysis Transplantation 2009; 24: 1051-1053.
41. Ludwig A, et al. Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus. Journal of Medical Virology 2008; 80: 1461-1467.
42. Simon A, et al. Norovirus outbreak in a pediatric oncology unit. Scandinavian Journal of Gastroenterology 2006; 41: 693-699.
43. Kirkwood CD, Streitberg R. Calicivirus shedding in children after recovery from diarrhoeal disease. Journal of Clinical Virology 2008; 43: 346-348.
44. Koopman JS, Longini IM. The ecological effects of individual exposures and nonlinear disease dynamics in populations. American Journal of Public Health 1994; 84: 836-842.
45. Matsui SM, Greenberg HB. Immunity to calicivirus infection. Journal of Infectious Diseases 2000; 181 (Suppl. 2): S331-S335.
46. Donaldson EF, et al. Viral shape-shifting: Norovirus evasion of the human immune system. Nature Reviews Microbiology 2010; 8: 231-241.
47. Grenfell BT, et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 2004; 303: 327-332.
48. Lindesmith LC, et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Medicine 2008; 5: 269-290.
49. Siebenga JJ, et al. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: A model for in vivo molecular evolution. Journal of Infectious Diseases 2008; 198: 994-1001.
50. Patel MM, et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerging Infectious Diseases 2008; 14: 1224-1231.
51. Goller JL, et al. Norovirus excretion in a healthcare worker without major symptoms of gastroenteritis: Infection control implications. Australian and New Zealand Journal of Public Health 2004; 28: 88-89.
52. Parashar UD, et al. An outbreak of viral gastroenteritis associated with consumptions of sandwiches: Implications for the control of transmission by food handlers. Epidemiology and Infection 1998; 121: 615-621. Results (STAR)